137 related articles for article (PubMed ID: 17308232)
1. Treatment of apathy with methylphenidate.
Padala PR; Burke WJ; Bhatia SC; Petty F
J Neuropsychiatry Clin Neurosci; 2007; 19(1):81-3. PubMed ID: 17308232
[TBL] [Abstract][Full Text] [Related]
2. Methylphenidate may treat apathy independent of depression.
Padala PR; Petty F; Bhatia SC
Ann Pharmacother; 2005 Nov; 39(11):1947-9. PubMed ID: 16204387
[TBL] [Abstract][Full Text] [Related]
3. Methylphenidate for apathy and functional status in dementia of the Alzheimer type.
Padala PR; Burke WJ; Shostrom VK; Bhatia SC; Wengel SP; Potter JF; Petty F
Am J Geriatr Psychiatry; 2010 Apr; 18(4):371-4. PubMed ID: 20220576
[TBL] [Abstract][Full Text] [Related]
4. Is there a role for psychostimulants in old age depression and apathy?
Ng B
Int Psychogeriatr; 2009 Apr; 21(2):417-8. PubMed ID: 19216822
[No Abstract] [Full Text] [Related]
5. Methylphenidate in the treatment of neurobehavioral slowing associated with cancer and cancer treatment.
Weitzner MA; Meyers CA; Valentine AD
J Neuropsychiatry Clin Neurosci; 1995; 7(3):347-50. PubMed ID: 7580196
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
Patkar AA; Masand PS; Pae CU; Peindl K; Hooper-Wood C; Mannelli P; Ciccone P
J Clin Psychopharmacol; 2006 Dec; 26(6):653-6. PubMed ID: 17110825
[TBL] [Abstract][Full Text] [Related]
7. Methylphenidate and depression.
Ng B
J Clin Psychopharmacol; 2008 Feb; 28(1):116-7; author reply 117-8. PubMed ID: 18204360
[No Abstract] [Full Text] [Related]
8. Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge.
Herrmann N; Rothenburg LS; Black SE; Ryan M; Liu BA; Busto UE; Lanctôt KL
J Clin Psychopharmacol; 2008 Jun; 28(3):296-301. PubMed ID: 18480686
[TBL] [Abstract][Full Text] [Related]
9. Predictors of response to adjunctive osmotic-release methylphenidate or placebo in patients with major depressive disorder: effects of apathy/anhedonia and fatigue.
Rizvi SJ; Geraci J; Ravindran A; Kennedy SH
J Clin Psychopharmacol; 2014 Dec; 34(6):755-9. PubMed ID: 25203470
[No Abstract] [Full Text] [Related]
10. Treatment of catatonia with methylphenidate in an elderly patient with depression.
Prowler ML; Weiss D; Caroff SN
Psychosomatics; 2010; 51(1):74-6. PubMed ID: 20118444
[TBL] [Abstract][Full Text] [Related]
11. Modafinil use in patients with a primary psychiatric illness.
Black W; Hoey P; Mayze T
Aust N Z J Psychiatry; 2010 Jun; 44(6):583-4. PubMed ID: 20482418
[No Abstract] [Full Text] [Related]
12. Methylphenidate in the treatment of geriatric patients with vascular depression: a retrospective chart review.
Mantani A; Fujikawa T; Ohmori N; Yamawaki S
Am J Geriatr Psychiatry; 2008 Apr; 16(4):336-7. PubMed ID: 18378559
[No Abstract] [Full Text] [Related]
13. Successful methylphenidate treatment of apathy after subcortical infarcts.
Watanabe MD; Martin EM; DeLeon OA; Gaviria M; Pavel DG; Trepashko DW
J Neuropsychiatry Clin Neurosci; 1995; 7(4):502-4. PubMed ID: 8555754
[TBL] [Abstract][Full Text] [Related]
14. Severity but not comorbidities predicts response to methylphenidate in adults with attention-deficit/hyperactivity disorder: results from a naturalistic study.
Victor MM; Rovaris DL; Salgado CA; Silva KL; Karam RG; Vitola ES; Picon FA; Contini V; Guimarães-da-Silva PO; Blaya-Rocha P; Belmonte-de-Abreu PS; Rohde LA; Grevet EH; Bau CH
J Clin Psychopharmacol; 2014 Apr; 34(2):212-7. PubMed ID: 24577256
[TBL] [Abstract][Full Text] [Related]
15. Methylphenidate in post liver transplant patients.
Plutchik L; Snyder S; Drooker M; Chodoff L; Sheiner P
Psychosomatics; 1998; 39(2):118-23. PubMed ID: 9584537
[TBL] [Abstract][Full Text] [Related]
16. Treating adult attention deficit hyperactivity disorder in hospitalized psychiatric patients.
Castaneda R; Levy R; Hazzi C; Ross S; Roman W; Hamid H
Gen Hosp Psychiatry; 2008; 30(6):572-7. PubMed ID: 19061685
[TBL] [Abstract][Full Text] [Related]
17. Medical use of psychostimulants: an overview.
Holmes VF
Int J Psychiatry Med; 1995; 25(1):1-19. PubMed ID: 7649714
[No Abstract] [Full Text] [Related]
18. Stimulant rebound: how common is it and what does it mean?
Carlson GA; Kelly KL
J Child Adolesc Psychopharmacol; 2003; 13(2):137-42. PubMed ID: 12880508
[TBL] [Abstract][Full Text] [Related]
19. A one year trial of methylphenidate in the treatment of ADHD.
Wender PH; Reimherr FW; Marchant BK; Sanford ME; Czajkowski LA; Tomb DA
J Atten Disord; 2011 Jan; 15(1):36-45. PubMed ID: 20071637
[TBL] [Abstract][Full Text] [Related]
20. Stimulants and other drugs for treatment of mental symptoms in the elderly.
Med Lett Drugs Ther; 1978 Aug; 20(17):75. PubMed ID: 28465
[No Abstract] [Full Text] [Related]
[Next] [New Search]
